Ingram Robert Alexander insider trades
Ingram Robert Alexander has filed 15 Form 4s with the SEC that we hold, for Biocryst Pharmaceuticals INC (BCRX) (Director) and Black Diamond Therapeutics, Inc. (BDTX) (Reporting owner). None of these filings reports a purchase (code P) or sale (code S) of common stock; they cover grants, option exercises and other codes. The first filing on our record is dated 2021-09-02 and the latest 2023-03-02.
Biocryst Pharmaceuticals INC (BCRX)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Black Diamond Therapeutics, Inc. (BDTX)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1219890) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms